There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Demant (WILLF – Research Report), Option Care Health (OPCH – Research Report) and Oculis Holding (OCS – Research Report) with bullish sentiments.
Demant (WILLF)
Bernstein analyst Susannah Ludwig maintained a Buy rating on Demant yesterday and set a price target of DKK330.00. The company’s shares closed last Tuesday at $42.50, equals to its 52-week high of $42.50.
Ludwig has an average return of
According to TipRanks.com, Ludwig is ranked #5963 out of 8537 analysts.
Demant has an analyst consensus of Moderate Buy, with a price target consensus of $43.83, which is a 3.1% upside from current levels. In a report issued on August 21, J.P. Morgan also upgraded the stock to Buy with a DKK340.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Option Care Health (OPCH)
In a report released yesterday, Joanna Gajuk from Bank of America Securities maintained a Buy rating on Option Care Health, with a price target of $41.00. The company’s shares closed last Tuesday at $35.04, close to its 52-week high of $35.87.
According to TipRanks.com, Gajuk is a 3-star analyst with an average return of
Currently, the analyst consensus on Option Care Health is a Strong Buy with an average price target of $42.00.
Oculis Holding (OCS)
Bank of America Securities analyst Jason Gerberry reiterated a Buy rating on Oculis Holding yesterday and set a price target of $24.00. The company’s shares closed last Tuesday at $13.37, close to its 52-week high of $14.50.
According to TipRanks.com, Gerberry is a 1-star analyst with an average return of
Currently, the analyst consensus on Oculis Holding is a Strong Buy with an average price target of $37.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on WILLF:
